Literature DB >> 308505

Cefotoxime (HR 756) a new cephalosporin with exceptional broad-spectrum activity in vitro.

J M Hamilton-Miller, W Brumfitt, A V Reynolds.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 308505     DOI: 10.1093/jac/4.5.437

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  43 in total

1.  Respiratory superinfections after the use of third-generation cephem antibiotics.

Authors:  A Saito; K Mori; Y Shigeno; K Yamaguchi; K Hara
Journal:  Infection       Date:  1985       Impact factor: 3.553

2.  Bone and joint infections caused by gram-positive bacteria: treatment with cefotaxime.

Authors:  J LeFrock; J Mader; B Smith; B Carr
Journal:  Infection       Date:  1985       Impact factor: 3.553

3.  Clinical experience with cefotaxime for the therapy of bacteremias due to gram-positive organisms.

Authors:  C J Schleupner
Journal:  Infection       Date:  1985       Impact factor: 3.553

4.  Clinical experience of cefotaxime in infections caused by gram-positive pathogens.

Authors:  D Bassetti; M Solbiati; G Fraizzoli
Journal:  Infection       Date:  1985       Impact factor: 3.553

5.  Human pharmacology of cefotaxime (HR 756), a new cephalosporin.

Authors:  R Lüthy; R Münch; J Blaser; H Bhend; W Siegenthaler
Journal:  Antimicrob Agents Chemother       Date:  1979-08       Impact factor: 5.191

6.  Comparison of activity and beta-lactamase stability of cefotaxime with those of six other cephalosporins.

Authors:  R P Mouton; G P Bongaerts; M van Gestel
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

7.  In vitro activity of LY127935, a new 1-oxa cephalosporin, against aerobic gram-negative bacilli.

Authors:  D G Delgado; C J Brau; C G Cobbs; W E Dismukes
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

8.  Ceftazidime, ceftizoxime, cefotaxime and HR 221 in experimental chronic Escherichia coli pyelonephritis in rats.

Authors:  R Marre; D Herhahn; E Schulz; H Freiesleben; K Sack
Journal:  Infection       Date:  1983       Impact factor: 3.553

9.  Ceftriaxone: in vitro activity against 410 bacterial isolates compared with cefotaxime.

Authors:  A Digranes; E Benonisen; W L Dibb
Journal:  Infection       Date:  1982 Sep-Oct       Impact factor: 3.553

10.  Mechanism of resistance of an ampicillin-resistant, beta-lactamase-negative clinical isolate of Haemophilus influenzae type b to beta-lactam antibiotics.

Authors:  T R Parr; L E Bryan
Journal:  Antimicrob Agents Chemother       Date:  1984-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.